adMare
News

adMare BioInnovations and MaRS Discovery District Welcome Inaugural Ontario Start-Ups to Therapeutics Accelerator Program

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

MaRS partners with adMare BioInnovations to develop Therapeutics Accelerator

adMare BioInnovations Launches the adMare Tx Accelerator to Support Growth of Promising Early-stage Therapeutics Ventures across Canada

adMare BioInnovations Collaborates with Accelerator Company, Molecular Forecaster Inc. on Computational Approaches to Drug Discovery

MONTREAL, QUEBEC, April 5, 2022 – Molecular Forecaster Inc. (MFI) is excited to announce a partnership with adMare BioInnovations (adMare) to deliver computer-aided drug design (CADD) resources to selected R&D…

adMare’s Accelerate Quebec Company, Molecular Forecaster, Continues Quest to Fast Track Drug Discovery with Two New Public-Private Partnerships

The company and its partners have secured CAD$1 million to apply and improve MFI’s virtual drug-design software in support of preclinical research targeting antibiotic-resistant bacteria and non-alcoholic fatty liver disease…

adMare BioInnovations Welcomes the First Quebec Start-Ups in its Accelerate Program

adMare today unveiled the six companies selected under its new acceleration program supported by the Quebec Government and the City of Montreal. Montréal, QC – December 10, 2020 – adMare BioInnovations,…

adMare BioInnovations Launches a New Acceleration Program for Quebec Emerging Companies

New program supported by the Quebec Government and the City of Montreal looks to scale-up the province’s most promising young life sciences companies. Montreal, QC – June 29th, 2020: adMare…